Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2008 Feb 26;98(4):852-3; author reply 854.
doi: 10.1038/sj.bjc.6604153. Epub 2007 Dec 18.

Missing ligand model in autologous stem cell transplantation

M Stern, M Paulussen, J Rischewski, A Tichelli, A Gratwohl
Comment

Missing ligand model in autologous stem cell transplantation

M Stern et al. Br J Cancer. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Disease-free survival (upper panel) and cumulative incidence of relapse (lower panel) are not different between patients with or without a missing KIR ligand after high-dose chemotherapy and autologous haematopoietic stem cell transplantation.
See this image and copyright information in PMC

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K, O'Reilly RJ, Horowitz MM, Dupont B (2005) Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood 105: 4878–4884 - PMC - PubMed
    1. Leung W, Handgretinger R, Iyengar R, Turner V, Holladay MS, Hale GA (2007) Inhibitory KIR–HLA receptor–ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma. Br J Cancer 97: 539–542 - PMC - PubMed
    1. Leung W, Iyengar R, Triplett B, Turner V, Behm FG, Holladay MS, Houston J, Handgretinger R (2005) Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J Immunol 174: 6540–6545 - PubMed
    1. Miller JS, Cooley S, Parham P, Farag SS, Verneris MR, McQueen KL, Guethlein LA, Trachtenberg EA, Haagenson M, Horowitz MM, Klein JP, Weisdorf DJ (2007) Missing KIR ligands are associated with less relapse and increased graft-vs-host disease (GVHD) following unrelated donor allogeneic HCT. Blood 109: 5058–5061 - PMC - PubMed